TY  - JOUR
A1  - Bowen, Tom
A1  - Cicardi, Marco
A1  - Farkas, Henriette
A1  - Bork, Konrad
A1  - Longhurst, Hilary
A1  - Zuraw, Bruce
A1  - Aygören-Pürsün, Emel
A1  - Craig, Timothy
A1  - Binkley, Karen
A1  - Hebert, Jacques
A1  - Ritchie, Bruce
A1  - Bouillet, Laurence
A1  - Betschel, Stephen
A1  - Cogar, Della
A1  - Dean, John
A1  - Devaraj, Ramachand
A1  - Hamed, Azza
A1  - Kamra, Palinder
A1  - Keith, Paul K.
A1  - Lacuesta, Gina
A1  - Leith, Eric
A1  - Lyons, Harriet
A1  - Mace, Sean
A1  - Mako, Barbara
A1  - Neurath, Doris
A1  - Poon, Man-Chiu
A1  - Rivard, Georges-Etienne
A1  - Schellenberg, Robert
A1  - Rowan, Dereth
A1  - Rowe, Anne
A1  - Stark, Donald
A1  - Sur, Smeeksha
A1  - Tsai, Ellie
A1  - Warrington, Richard
A1  - Waserman, Susan
A1  - Ameratunga, Rohan
A1  - Bernstein, Jonathan A.
A1  - Björkander, Janne
A1  - Brosz, Kristylea
A1  - Brosz, John
A1  - Bygum, Anette
A1  - Caballero, Teresa
A1  - Frank, Mike
A1  - Fust, George
A1  - Harmat, George
A1  - Kanani, Amin
A1  - Kreuz, Wolfhart
A1  - Levi, Marcel M.
A1  - Li, Henry
A1  - Martinez Saguer, Inmaculada
A1  - Moldovan, Dumitru
A1  - Nagy, Istvan
A1  - Nielsen, Erik W.
A1  - Nordenfelt, Patrik
A1  - Reshef, Avner
A1  - Rusicke, Eva
A1  - Smith-Foltz, Sarah
A1  - Späth, Peter
A1  - Varga, Lilian
A1  - Xiang, Zhi Yu
T1  - 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
T2  - Allergy, Asthma & Clinical Immunology
N2  - Background We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angioedema: a current state-of-the-art review: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Objective To update the International Consensus Algorithm for the Diagnosis, Therapy and Management of Hereditary Angioedema (circa 2010). Methods The Canadian Hereditary Angioedema Network (CHAEN)/Reseau Canadien d'angioedeme hereditaire (RCAH) (www.haecanada.com) and cosponsors University of Calgary and the Canadian Society of Allergy and Clinical Immunology (with an unrestricted educational grant from CSL Behring) held our third Conference May 15th to 16th, 2010 in Toronto Canada to update our consensus approach. The Consensus document was reviewed at the meeting and then circulated for review. Results This manuscript is the 2010 International Consensus Algorithm for the Diagnosis, Therapy and Management of Hereditary Angioedema that resulted from that conference. Conclusions Consensus approach is only an interim guide to a complex disorder such as HAE and should be replaced as soon as possible with large phase III and IV clinical trials, meta analyses, and using data base registry validation of approaches including quality of life and cost benefit analyses, followed by large head-to-head clinical trials and then evidence-based guidelines and standards for HAE disease management.
Y1  - 2010
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7883
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30-78325
N1  - © 2010 Bowen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
VL  - 6
IS  - 24
ER  -